Diagnosis and Treatment of Ischemia-Producing Coronary Stenoses Improves 5-year Survival of Patients Undergoing Major Vascular Surgery.

Peripheral artery disease coronary CT-derived fractional flow reserve ischemia-guided coronary revascularization long-term survival major vascular surgery silent coronary ischemia

Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
20 Mar 2024
Historique:
received: 26 01 2024
revised: 22 02 2024
accepted: 24 02 2024
medline: 23 3 2024
pubmed: 23 3 2024
entrez: 22 3 2024
Statut: aheadofprint

Résumé

Patients undergoing vascular surgery procedures have poor long-term survival due to coexisting coronary artery disease (CAD) which is often asymptomatic, undiagnosed and undertreated. We sought to determine whether pre-operative diagnosis of asymptomatic (silent) coronary ischemia using coronary CT -derived fractional flow reserve (FFR In this observational cohort study of 522 patients with no known CAD undergoing elective carotid, peripheral or aneurysm surgery we compared two groups of patients. Group I: 288 patients enrolled in a prospective IRB-approved study of pre-operative coronary CTA and FFR The two groups were similar in age, gender, and comorbidities. In FFR Diagnosis of silent coronary ischemia with ischemia-targeted coronary revascularization in addition to BMT following major vascular surgery was associated with fewer adverse cardiovascular events and improved 5-year survival compared patients treated with BMT alone as per current guidelines.

Sections du résumé

BACKGROUND BACKGROUND
Patients undergoing vascular surgery procedures have poor long-term survival due to coexisting coronary artery disease (CAD) which is often asymptomatic, undiagnosed and undertreated. We sought to determine whether pre-operative diagnosis of asymptomatic (silent) coronary ischemia using coronary CT -derived fractional flow reserve (FFR
METHODS METHODS
In this observational cohort study of 522 patients with no known CAD undergoing elective carotid, peripheral or aneurysm surgery we compared two groups of patients. Group I: 288 patients enrolled in a prospective IRB-approved study of pre-operative coronary CTA and FFR
RESULTS RESULTS
The two groups were similar in age, gender, and comorbidities. In FFR
CONCLUSIONS CONCLUSIONS
Diagnosis of silent coronary ischemia with ischemia-targeted coronary revascularization in addition to BMT following major vascular surgery was associated with fewer adverse cardiovascular events and improved 5-year survival compared patients treated with BMT alone as per current guidelines.

Identifiants

pubmed: 38518962
pii: S0741-5214(24)00500-7
doi: 10.1016/j.jvs.2024.02.043
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Dainis K Krievins (DK)

Pauls Stradins Clinical University Hospital, Riga, Latvia; University of Latvia, Riga, Latvia. Electronic address: Dainis.krievins@stradini.lv.

Edgars Zellans (E)

Pauls Stradins Clinical University Hospital, Riga, Latvia; University of Latvia, Riga, Latvia.

Gustavs Latkovskis (G)

Pauls Stradins Clinical University Hospital, Riga, Latvia; University of Latvia, Riga, Latvia.

Indulis Kumsars (I)

Pauls Stradins Clinical University Hospital, Riga, Latvia; University of Latvia, Riga, Latvia.

Agate K Krievina (AK)

University of Latvia, Riga, Latvia.

Sanda Jegere (S)

Pauls Stradins Clinical University Hospital, Riga, Latvia; University of Latvia, Riga, Latvia.

Andrejs Erglis (A)

Pauls Stradins Clinical University Hospital, Riga, Latvia; University of Latvia, Riga, Latvia.

Aigars Lacis (A)

Pauls Stradins Clinical University Hospital, Riga, Latvia.

Erika Plopa (E)

Riga Stradins University, Riga, Latvia.

Peteris Stradins (P)

Pauls Stradins Clinical University Hospital, Riga, Latvia; Riga Stradins University, Riga, Latvia.

Patricija Ivanova (P)

University of Latvia, Riga, Latvia.

Christopher K Zarins (CK)

HeartFlow,Inc. Mountain View, California.

Classifications MeSH